Toggle navigation
Home
Search
Services
Blog
Contact
About
In Vitro Antineoplastic Drug Toxicology Characterization
Murphy, Martin
Hipple Cancer Research Corporation, Dayton, OH, United States
Search 58 grants from Martin Murphy
Search grants from Hipple Cancer Research Corporation
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Examination of the Feasibility and Preliminary Efficacy of Yoga as an Intervention Approach to Improving Long-Term Weight Loss
Control of Growth of Vascular Wall Cells
Japan JSPS Program: Novel Single Electron Coulomb Blockade Transistor as a Proble in the Study of Si02/Si Interface
U.S.-Mexico Cooperative Research: Some Theoretical and Numerical Problems in Differential Equations
U.S.-Mexico Cooperative Research: Ecological, Microbial and Physiological Monitoring of Free-Ranging Mexican Bolson Tortoises, an Endangered Species
Recently added grants:
Branched Chain Amino Acids and Heart Failure
Patient Specific Tissue Engineered Vascular Graft Creation Using 3D Printing Technology
Care Coordination for High-Risk Patients with Multiple Chronic Conditions
Direct quantitation of the circulating Mtb-peptidome for pediatric TB management
SPAK inhibitor ZT-1a for ischemic stroke therapy
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Treatment (NCI)
Type
Small Business Innovation Research – Phase II (N44)
Project #
N44CM027361-004
Application #
3609936
Study Section
Project Start
1992-08-01
Project End
1994-07-31
Budget Start
1993-06-30
Budget End
1994-07-31
Support Year
Fiscal Year
1993
Total Cost
Indirect Cost
Institution
Name
Hipple Cancer Research Corporation
Department
Type
DUNS #
City
Dayton
State
OH
Country
United States
Zip Code
45439
Related projects
NIH 1993
N44 CM
In Vitro Antineoplastic Drug Toxicology Characterization
Murphy, Martin / Hipple Cancer Research Corporation
NIH 1992
N44 CM
In Vitro Antineoplastic Drug Toxicology Characterization
Murphy, Martin / Hipple Cancer Research Corporation
Comments
Be the first to comment on Martin Murphy's grant